Growing Market Presence ProSomnus has demonstrated consistent growth, as evidenced by its inclusion on the Inc. 5000 list of fastest growing private companies and recent recognition in the manufacturing sector, indicating increasing market acceptance and expanding sales opportunities.

Strategic Investment Backing A recent $38 million investment from Catalio Capital Management enhances ProSomnus's capacity to scale its Smart Sleep Medicine products, presenting opportunities to collaborate on new initiatives or leverage their expanded resources for product expansion.

Innovative Product Launches The introduction of EVO Guided and other precision intraoral devices positions ProSomnus at the forefront of non-invasive OSA therapies, suggesting strong potential for upselling advanced treatment solutions to healthcare providers.

Healthcare Coverage Advantage With FDA-cleared, patented devices covered by major insurance plans serving over 200 million lives, there is a significant opportunity to expand provider networks and promote coverage options to increase patient adoption.

Technological Edge Utilization of advanced design tools like AutoCAD and SOLIDWORKS through the company indicates a focus on precision engineering and innovation, making them a compelling partner for technologically sophisticated medical device collaborations.